explore -WSS

explore

author：hotspot 2025-09-27 06:03:16 - browse：5132

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Involuntary treatment for addiction doesn't work

hotspot

knowledge

WSS

Elevance PBM president out as customers face prescription chaos

Finland to offer bird flu vaccine to select groups of people, a possible global first

Everything to know for the next Powerball drawing as jackpot hits $1 billion

CMS got Medicare Advantage quality rating wrong, judge rules

STAT wants to know your pick for a great summer read or listen

Celiac disease study examines precisely how gluten triggers injury

explore

explore

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Medicare Advantage's lean provider networks lead CMS complaints

Sports medicine is finally prioritizing gender equality

The most pressing bird flu mysteries scientists want answered

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

An outdated Medicare rule harms dementia patients with anxiety

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

For pregnant people, addiction treatment shouldn't mean a call to child protective services

DIEP, the 'gold standard' of breast reconstruction, is under threat

ASCO Takeaways: Winners, snoozers, and the art of cancer care

explore

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Anthony Fauci pushes back on GOP claims during Covid hearing

Stopping antidepressants leads to symptoms for 1 in 6 patients

UnitedHealth CEO's Medicaid comments send insurer stocks diving

BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

hotspot

knowledge

explore